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Abstract. 
 
Cytoplasmic dynein is the major minus end–
directed microtubule motor in animal cells, and associates
with many of its cargoes in conjunction with the dynactin
complex. Interaction between cytoplasmic dynein and
dynactin is mediated by the binding of cytoplasmic dy-
nein intermediate chains (CD-IC) to the dynactin sub-
unit, p150
 
Glued
 
. We have found that both CD-IC and
p150
 
Glued
 
 are cleaved by caspases during apoptosis in cul-
tured mammalian cells and in 
 
Xenopus
 
 egg extracts. 
 
Xe-
nopus
 
 CD-IC is rapidly cleaved at a conserved aspartic
acid residue adjacent to its NH
 
2
 
-terminal p150
 
Glued
 
 bind-
ing domain, resulting in loss of the otherwise intact cyto-
plasmic dynein complex from membranes. Cleavage of
CD-IC and p150
 
Glued
 
 in apoptotic 
 
Xenopus
 
 egg extracts
causes the cessation of cytoplasmic dynein–driven en-
doplasmic reticulum movement. Motility of apoptotic
membranes is restored by recruitment of intact cyto-
plasmic dynein and dynactin from control cytosol, or
from apoptotic cytosol supplemented with puriﬁed cy-
toplasmic dynein–dynactin, demonstrating the dynamic
nature of the association of cytoplasmic dynein and dy-
nactin with their membrane cargo.
Key words: microtubule • motor • apoptosis • traf-
ﬁcking • caspase
 
Introduction
 
Apoptosis, or programmed cell death, is accompanied by
the activation of a family of apoptosis-specific cysteine pro-
teases called caspases (Cohen, 1997). Both the signaling
pathways that mediate caspase activation, and the sub-
strates for caspases, are highly conserved. The so-called ex-
ecution phase of apoptosis involves a characteristic series of
morphological changes that in many cases are directly cou-
pled to caspase-dependent cleavage of key substrates.
These events ultimately lead to the recognition and engulf-
ment of dying cells by their neighbors. The nature of the
phagocytic signal generated by the apoptotic cell is not
known, but is likely to be complex. This is perhaps best illus-
trated by the finding that “professional” and “nonprofes-
sional” phagocytic cells clear apoptotic cells at different
rates, with the latter recognizing apoptotic cells only after the
execution phase has run its full course (Parnaik et al., 2000).
The exposure of phosphatidyl serine on the surface of
apoptotic cells is thought to be a key phagocytic signal
(Martin et al., 1995; Fadok et al., 2000; Hamon et al.,
2000), but other markers are clearly important (Savill et
al., 1990; Ren et al., 1995; Platt et al., 1996; Devitt et al.,
1998). Indeed, since such widely recognized phagocytic
signals must be generic, it is probable that general alter-
ations in the protein composition of the plasma mem-
brane, or in the glycosylation of proteins or lipids, are also
involved. Such changes could be brought about by altering
the specificity or efficiency of membrane traffic pathways.
In support of this hypothesis, there is evidence that both
the secretory and endocytic pathways are affected in apop-
totic cells. There are profound changes in membrane
structure (Wyllie et al., 1980), including fragmentation of
the Golgi complex (Mancini et al., 2000) and inhibition of
the secretory pathway (Whyte et al., 1993). In addition,
homotypic endosome fusion is inhibited in apoptotic cell
extracts via the caspase 3–dependent cleavage of Rabaptin
5 (Cosulich et al., 1997; Swanton et al., 1999a).
The secretory and endocytic pathways rely in numerous
ways on the function of cytoplasmic dynein and its regulator
dynactin. They are required for ER-to-Golgi region traffic
(Presley et al., 1997), for maintaining Golgi apparatus organi-
zation and position (Burkhardt et al., 1997; Harada et al., 1998;
Quintyne et al., 1999; Roghi and Allan, 1999), and for moving
endocytic organelles and facilitating traffic between them
(Blocker et al., 1997; Harada et al., 1998; Valetti et al., 1999).
The ER itself is a cargo for cytoplasmic dynein in extracts of
 
Xenopus
 
 eggs and early embryos (Allan, 1995; Lane and Al-
lan, 1999). In addition to these roles in trafficking, cytoplasmic
dynein, and dynactin are also needed for maintaining microtu-
bule organization in interphase, as well as for correct spindle
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assembly, positioning, and chromosome attachment during
cell division (for review see Karki and Holzbaur, 1999).
The central importance of cytoplasmic dynein in main-
taining cellular architecture makes it an attractive target
for inactivation during apoptosis. Cytoplasmic dynein is a
large molecule (
 
 
 
1.2 MDa) which consists of two heavy
chains (CD-HC),
 
1
 
 two or three intermediate chains (CD-
IC), four light intermediate chains (CD-LIC), and a variety
of light chains (for review see Susalka et al., 2000). More
than one gene exists for the heavy, intermediate, and light
intermediate chains, and in addition, the CD-ICs and the
CD-LICs undergo tissue-specific alternate splicing (Su-
salka et al., 2000). Whether different subsets of these chains
associate to give cytoplasmic dynein molecules with distinct
function is not clear, but seems likely (Susalka et al., 2000).
Cytoplasmic dynein function generally requires dynactin,
first identified as an activator of cytoplasmic dynein–driven
vesicle movement (Gill et al., 1991). Dynactin also consists
of multiple subunits, including two p150
 
Glued
 
 chains which
extend out from a short filament of actin-related protein 1
which associates with a variety of other subunits, including
several dynamitin molecules (Schafer et al., 1994; Quintyne
et al., 1999). Genetic and biochemical studies have con-
firmed that the two complexes must interact for virtually all
cytoplasmic dynein functions (for review see Allan, 1996;
Schroer, 1996; Karki and Holzbaur, 1999). Dynactin is
thought to link cytoplasmic dynein to its cargoes (for re-
view see Allan, 1996; Schroer, 1996; Karki and Holzbaur,
1999) and to enhance cytoplasmic dynein’s processivity
(King and Schroer, 1999). How dynactin attaches to car-
goes is not clear, but it might bind directly to membrane
lipids, or interact with proteins such as beta spectrin on the
Golgi apparatus or ZW10 on the kinetochore (Karki and
Holzbaur, 1999; Muresan et al., 2001). Cytoplasmic dynein
then binds to dynactin via an interaction between p150
 
Glued
 
and the NH
 
2
 
-terminal domain of CD-IC (Karki and
Holzbaur, 1995; Vaughan and Vallee, 1995).
A convenient system for studying cytoplasmic dynein
function during apoptosis is provided by 
 
Xenopus
 
 egg ex-
tracts, which support active cytoplasmic dynein–driven ER
movement (Allan, 1995; Niclas et al., 1996; Lane and Allan,
1999) and can readily be made apoptotic (Kluck et al.,
1997). Here, we show that CD-IC and p150
 
Glued
 
 are cleaved
by caspases both in apoptotic egg extracts and during apop-
tosis in vivo. The implications of these cleavage events for
cytoplasmic dynein–dynactin function are described.
 
Materials and Methods
 
Chemicals and Antibodies
 
Unless otherwise stated, chemicals were obtained from Sigma-Aldrich.
Stock solutions were stored at 
 
 
 
20
 
 
 
C: anisomycin (5 mg/ml in DMSO),
etoposide (50 mM in DMSO), and caspase inhibitors (Ac-DEVD.CHO at
100 
 
 
 
M and zVAD.FMK at 50 
 
 
 
M, both in DMSO; Calbiochem-Nova-
biochem). Protease inhibitors (leupeptin, chymostatin, pepstatin, and
aprotinin) were used at 10 
 
 
 
g/ml final concentration.
For immunoblotting, we used the following monoclonal antibodies:
anti–CD-IC (70.1, Sigma-Aldrich; 1618, Chemicon International), anti-
p150
 
Glued
 
 (Transduction Labs), antifodrin (ICN Biomedicals), antitubulin
(B-5-1-2), antiribophorin (CEL5C, from Birgit Lane, University of
Dundee, Dundee, UK), antikinesin II (K 2.4, from John Scholey, Univer-
sity of California at Davis, Davis, CA), and anti-p50 dynamitin (from
Richard Vallee, University of Massachusetts, Worcester, MA); and the
following polyclonal antibodies: anti-rat CD-IC (from Richard Vallee;
Vaughan and Vallee, 1995), anti-
 
Xenopus 
 
CD-LIC (Addinall et al., 2001),
anti–CD-IC NH
 
2
 
 terminus (
 
Xenopus-
 
specific; Lane and Allan, 1999), anti-
 
Xenopus
 
 CD-IC peptide antibody (raised and affinity purified against the
sequence NRSNKRTPVQRTPLS; underlined in Fig. 3), anti–poly-ADP-
ribose polymerase (PARP; Calbiochem), antikinesin heavy chain (KHC;
from Ron Vale, University of California at San Francisco, San Francisco,
CA), anti–
 
 
 
-COP (D1; from Thomas Kreis, University of Geneva,
Geneva, Switzerland), and anti–Arp-1 (centractin; from David Meyer,
University of California at Los Angeles, Los Angeles, CA). Secondary an-
tibodies (conjugated to alkaline phosphatase or horse radish peroxidase)
were from Jackson ImmunoResearch Laboratories.
 
Extract Preparation and Analysis
 
HL60 cells were grown in RPMI 1640 plus 10% foetal bovine serum and
penicillin/streptomycin. To analyze apoptosis in vivo, cells were treated
with 5 
 
 
 
g/ml anisomycin or 50 
 
 
 
M etoposide, with or without a 30 min
preincubation with 50 
 
 
 
M zVAD-FMK. Cells were washed three times in
PBS, then broken by passing 20 times through a cell cracker (Balch et al.,
1984) in acetate/sucrose buffer (100 mM K-acetate, 3 mM Mg-acetate, 5
mM EGTA, 10 mM Hepes, pH 7.4, 150 mM sucrose) containing protease
inhibitors. Postnuclear supernatants were prepared and stored at 
 
 
 
80
 
 
 
C.
Interphase 
 
Xenopus 
 
egg extracts were prepared as described (Murray,
1991). Apoptotic or control extracts were generated by the addition of cy-
tochrome 
 
c 
 
(to 10 
 
 
 
M) 
 
 
 
 the caspase inhibitor, Ac-DEVD-CHO (2 
 
 
 
M),
followed by incubation for 8 h at 25
 
 
 
C. Cytosol and membranes were pre-
pared from control and apoptotic extracts, and membranes were further
purified by flotation (Lane and Allan, 1999). For biochemical analysis of
rebinding to membrane, isolated membranes (10 
 
 
 
l 5 mg/ml protein) were
incubated in 90 
 
 
 
l control or apoptotic cytosol at 25
 
 
 
C for 60 min. The mix-
ture was then centrifuged in a rotor (TLA100; Beckman Coulter) for 15
min at 40,000 
 
g
 
av
 
 at 4
 
 
 
C through a 150-
 
 
 
l cushion of 0.75 M sucrose in ace-
tate buffer. The pelleted membranes were analyzed by immunoblotting.
 
Biochemical Analysis of Motor Complexes
 
Cytoplasmic dynein and dynactin were isolated from 400 
 
 
 
l control or ap-
optotic cytosols by microtubule affinity and sucrose density gradient cen-
trifugation as described (Niclas et al., 1996). 50-
 
 
 
l fractions were collected
and run on 4–15% gradient acrylamide gels then analyzed by silver stain-
ing and immunoblotting. Immunoprecipitation experiments were per-
formed as described (Roghi and Allan, 1999). In brief, 20 
 
 
 
l of control or
apoptotic egg cytosol was diluted to 500 
 
 
 
l in immunoprecipitation buffer
then incubated with protein G Sepharose beads (Zymed Laboratories)
prebound with anti–CD-IC (1618) or anti–CD-LIC antibodies.
 
Motility Assays and Data Collection
 
Motility assays were performed using video-enhanced differential inter-
ference contrast (VE-DIC) microscopy using a light microscope (BX60;
Olympus) (Allan, 1998). To compensate for differences in microtubule as-
sembly between control and apoptotic cytosols, a uniform field of stable
microtubules was assembled. Flow cells were perfused with diluted con-
trol egg cytosol (1:20 in acetate/sucrose) for 5 min. After two washes with
10 
 
 
 
l acetate/sucrose, taxol-stabilized microtubule seeds (Allan and Vale,
1991) were added. After 10 min, soluble tubulin (5 mg/ml) plus 1 mM
GTP was introduced, and microtubules were allowed to grow for 15 min.
Microtubules were stabilized by flowing through 20 
 
 
 
M taxol in acetate/
sucrose, washed once with acetate/sucrose, and then a mix of cytosol and
membranes was added. Over time, ER networks assemble on the cover-
slip surface in a cytoplasmic dynein–dependent fashion. Network forma-
tion was quantitated after 45 min by counting the number of three way
junctions in 20 random fields, which correlate directly with the quantity of
cytoplasmic dynein–based movement (Allan, 1995). Motility experiments
were carried out in the presence of 2 
 
 
 
M Ac-DEVD-CHO to prevent fur-
ther caspase action.
 
PCR and Cloning of Xenopus CD-IC
 
The first 288 bases of 
 
Xenopus 
 
CD-IC were obtained from a frog oocyte
cDNA library (Nicolás et al., 1997) by degenerate PCR using the follow-
 
1
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ing primers: forward, GGGGATCCATGTC(I)GA(CT)AA(AG)AG-
(CT)GA(I)(CT)T(I)AA; reverse, GGAATTC(AG)TC(CT)TG(AG)C-
T(I)CC(I)GC(AG)CT(I)GG. The PCR product was cloned into pBlue-
script (pBSIIsk
 
 
 
; Stratagene), and was used to prepare a probe to screen
the oocyte cDNA library to obtain a full-length 
 
Xenopus
 
 CD-IC clone. A
single clone was isolated, the sequence of which was most similar to CD-
IC2B (these sequence data are available from EMBL/GenBank/DDBJ un-
der accession nos. AF319780 and AF319781). The clone lacked the first 90
bases from the 5
 
 
 
 end, so to obtain a full-length construct it was joined to
the original PCR product using a conserved NsiI site within the overlapping
region. Site-directed mutagenesis was performed using the QuikChange kit
(Stratagene). All mutations were confirmed by sequencing.
 
In Vitro Transcription/Translation
 
The full-length 
 
Xenopus 
 
CD-IC construct was subcloned into the expres-
sion vector, pCDNA3.1 (Invitrogen). [
 
35
 
S]methionine-labeled protein was
produced using a coupled transcription/translation kit (Promega). Trans-
lations were analyzed by autoradiography. Translated 
 
Xenopus
 
 CD-IC
appeared as several 60–85-kD bands (data not shown), which were proba-
bly derived from random initiation events, so CD-IC was routinely immu-
noprecipitated using an NH
 
2
 
-terminal anti–CD-IC antibody (1618). The
immunecomplex was then used in caspase cleavage assays. Recombinant
PARP and caspase 2 were prepared as described (Swanton et al., 1999b).
 
Caspase Cleavage Assays
 
Assays using recombinant caspases 2, 3, and 7 (Alexis Biochemicals; and
from Don Nicholson and Sophie Roy [Merk Frosst Centre for Therapeu-
tic Research, Quebec, Canada]) were performed in caspase buffer (for
caspases 3 and 7; 50 mM Hepes-KOH, pH 7.0, 2 mM EGTA, 0.1% Chaps,
10% sucrose, 5 mM DTT; for caspase 2, 50 mM Na-citrate, pH 5.5 re-
placed the Hepes-KOH). Fractions enriched in native 
 
Xenopus
 
 or pig
brain cytoplasmic dynein–dynactin were incubated with caspases for 3 h at
37
 
 
 
C and analyzed by silver staining and immunoblotting.
Cleavage of in vitro–translated, immunoprecipitated, [
 
35
 
S]methionine-
labeled 
 
Xenopus
 
 CD-IC was carried out either by incubating beads in con-
trol or apoptotic egg cytosol for 6 h at 25
 
 
 
C, or by incubating beads in the
presence of recombinant caspases for 2 h at 30
 
 
 
C. Radiolabeled products
were detected by autoradiography. For some experiments the caspase 3
and 7 inhibitor, Casputin™ (Biomol Research Laboratories, Inc.; 80 
 
 
 
g/
ml final) was included.
 
Results
 
CD-IC and p150
 
Glued
 
 Are Targets 
for Caspases during Apoptosis
 
To investigate whether the inactivation of microtuble mo-
tors might contribute to the changes in cell morphology as-
sociated with apoptosis, we assessed the stability of a vari-
ety of molecules after activation of caspases in intact cells.
We used a number of cell lines (including human HL60,
jurkat and A431, and rat NRK) treated with a selection of
drugs (anisomycin, etoposide, staurosporine, or campto-
thecin). Most molecules tested (namely KHC, kinesin II, p50
dynamitin, 
 
 
 
-COP, and tubulin [Fig. 1 A]) were not al-
tered during apoptosis. However, loss of immunoreactivity
of both CD-IC and the p150
 
Glued
 
 component of the dynac-
tin complex was seen in apoptotic cells (Fig. 1, A and B).
In HL60 cells undergoing apoptosis in response to 5 
 
 
 
g/ml
anisomycin or 50 
 
 
 
M etoposide (Fig. 1 B), CD-IC rapidly
became undetectable at about the same rate that the char-
acterized caspase substrate PARP was cleaved. This sug-
gests that CD-IC may be an early target for caspases. The
reduction in p150
 
Glued
 
 signal was more gradual, mirroring
the loss of full-length fodrin immunoreactivity (Fig. 1 B).
In each case, loss of immunoreactivity was greatly reduced
by the cell permeable caspase inhibitor zVAD-FMK.
To study how caspase-dependent cleavage of CD-IC and
p150
 
Glued
 
 affect the function of the cytoplasmic dynein–
dynactin complex, we examined the cleavage of both proteins
in vitro using 
 
Xenopus
 
 egg extracts, since they are well-
suited for studying motor proteins (Allan and Vale, 1991)
and apoptosis (Newmeyer et al., 1994). Apoptosis can be
triggered in cell-free extracts by the addition of cyto-
chrome 
 
c
 
 (Liu et al., 1996; Kluck et al., 1997), whereupon
effector caspases are activated (e.g., Swanton et al., 1999b).
A clear reduction in recognition of CD-IC by NH
 
2
 
-termi-
nal monoclonal antibodies was seen upon addition of cyto-
chrome 
 
c
 
 to 
 
Xenopus
 
 egg extracts, but no cleavage prod-
ucts were detected (Fig. 1 C). This loss of signal occurred
over a similar time scale to the cleavage of other caspase
substrates in 
 
Xenopus
 
 extracts (Newmeyer et al., 1994; Co-
sulich et al., 1996) and was prevented by the caspase inhib-
itor Ac-DEVD-CHO (Fig. 1 C). In contrast, the mono-
clonal antibody to p150
 
Glued
 
 detected a cleavage product in
apoptotic egg extracts, 
 
 
 
10–20 kD smaller than the native
molecule (Fig. 1 C); no such product was seen in HL60 ex-
tracts, although the p150
 
Glued
 
 antibody reactivity was lost
with time (Fig. 1, A and B). We do not yet know why the
pattern of p150
 
Glued
 
 cleavage differs in these two systems.
 
CD-IC Is Cleaved within Its NH
 
2
 
-terminal
p150
 
Glued
 
 Binding Domain
 
To drive the movement of a variety of cargoes towards the
minus ends of microtubules, cytoplasmic dynein interacts
with dynactin through binding of the NH
 
2
 
 terminus of CD-
IC to p150
 
Glued
 
 (Fig. 2, A and B; Karki and Holzbaur, 1995;
Vaughan and Vallee, 1995). This region of CD-IC is recog-
nized by both monoclonal antibodies 70.1 and 1618 (data
not shown). Since neither antibody recognized cleavage
products in apoptotic cells and extracts (Fig. 1), this sug-
gested that caspase-dependent cleavage occurs within this
region. To test this hypothesis, we used a polyclonal anti-
serum raised against full-length rat CD-IC (Vaughan and
Vallee, 1995), and a peptide antibody raised against a se-
quence towards the COOH-terminus of CD-IC (see Mate-
rials and Methods; Fig. 3). In immunoblots of apoptotic
 
Xenopus
 
 egg extracts, these antibodies revealed a cleavage
product 
 
 
 
12 kD smaller than the molecular mass of the
full-length molecule (Fig. 2 C). These data suggest that
CD-IC is cleaved by caspases within its NH
 
2
 
-terminal
p150
 
Glued
 
 binding domain.
Comparison of multiple CD-IC sequences revealed sev-
eral conserved aspartic acids towards the NH
 
2
 
 terminus of
the molecule (Fig. 3). To identify the caspase cleavage site,
we used site-directed mutagenesis to alter these aspartic
acids to alanine, and examined the cleavage of in vitro–
translated, [
 
35
 
S]methionine-labeled protein when added to
apoptotic egg cytosol. Two cleaved products were gener-
ated from in vitro–translated wild-type 
 
Xenopus
 
 CD-IC
(Fig. 4 A): one at 
 
 
 
74 kD (C
 
1
 
) and one at 
 
 
 
66 kD (C
 
2
 
). C
 
1
 
matches the size of the product seen in immunoblots of ap-
optotic egg extracts using the polyclonal anti–CD-IC (Fig.
2 C), whereas we have never observed a band of the size of
C
 
2
 
, perhaps because the C
 
2
 
 cleavage site is inaccessible
when CD-IC is in the native cytoplasmic dynein complex.
Mutating the putative site DSGD
 
99
 
G (D
 
→
 
A) resulted in
the loss of the upper cleavage product (C
 
1
 
) (Fig. 4 A). 
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None of the other mutations altered the pattern of cleav-
age of 
 
Xenopus 
 
CD-IC (data not shown).
Since DSGD
 
99
 
G fits with consensus sites for caspase 3
(DXXD motif), we tested the effects of the selective
caspase 3 and 7 inhibitor, Casputin™. This inhibitor pre-
vented cleavage of in vitro–translated wild-type CD-IC to
C
 
1
 
 (Fig. 4 A), suggesting that this product is generated by
caspase 3 or caspase 7 in apoptotic egg extracts. We then
tested the ability of recombinant caspases 2, 3, and 7 to
cleave in vitro–translated, immunoprecipitated CD-IC
(Fig. 4, B–D). These caspases were shown to be active by
incubating them with known substrates. All three caspases
cleaved CD-IC to generate C
 
1
 
, to varying degrees, with
caspase 3 being most effective. From these data, caspase 3
is the best candidate for cleaving CD-IC at DSGD
 
99
 
G.
To confirm that CD-IC within native cytoplasmic dy-
nein could be cleaved by caspase 3, we carried out in vitro
cleavage assays using recombinant caspases 2 and 3, and
cytoplasmic dynein–dynactin fractions prepared from 
 
Xe-
nopus 
 
eggs (Fig. 4 E). Using immunoblotting, we demon-
strated that endogenous 
 
Xenopus 
 
CD-IC was degraded in
vitro
 
 
 
by caspase 3, but much less so by caspase 2 (Fig. 4 E).
Caspase 3, but not 2, also cleaved some of the p150
 
Glued
 
present within the same fraction (Fig. 4 E). The inclusion
of Ac-DEVD-CHO in these assays prevented caspase-
mediated CD-IC and p150
 
Glued
 
 cleavage. Identical results
were obtained using pig brain cytoplasmic dynein–dynac-
tin (data not shown).
Figure 1. CD-IC and p150Glued are cleaved during apoptosis.
(A) Cytosols were made from untreated human HL60 cells (C),
cells treated with anisomycin (A; 5  g/ml) for 4 h, and cells
treated with anisomycin and the cell-permeable capsase inhibitor
zVAD.FMK (Z). Equal amounts of protein were analyzed by sil-
ver staining (left) and immunoblotting. The positions of full-
length   -COP and p50 are shown ( ). (B) HL60 cells were
treated with 5  g/ml anisomycin or 50  M etoposide. Cell ex-
tracts prepared at the indicated times were immunoblotted using
the antibodies shown. Samples treated for the maximum times
with each agent in the presence of zVAD.FMK are also shown
(Z). (C) A Xenopus egg extract was incubated with 10  M cyto-
chrome c   the caspase inhibitor Ac-DEVD-CHO for the times
indicated. Extracts were then analyzed by immunoblotting. In all
panels, the anti–CD-IC antibody used was 70.1.
Figure 2. Cleavage of CD-IC takes place within its NH2-termi-
nal p150Glued binding region. (A) Schematic diagram of cytoplas-
mic dynein and dynactin, showing the interaction between the
NH2 terminus of CD-IC and p150Glued. (B) Representation of
CD-IC showing the regions that interact with other components
of the cytoplasmic dynein and dynactin complexes. (C) Immuno-
blot of a Xenopus egg extract that had been treated for the times
indicated (in hours) with cytochrome c   Ac-DEVD-CHO using
monoclonal (70.1) and polyclonal antibodies to CD-IC. The posi-
tions of molecular weight markers are also shown.Lane et al. Apoptotic Loss of Cytoplasmic Dynein Function 1419
Figure 3. Amino acid se-
quence of Xenopus laevis (Xl)
CD-IC aligned with the NH2
terminus of rat (Rn) CD-IC1,
2A, 2B, and 2C. The locations
of several potential caspase
cleavage motifs are high-
lighted. In each of these, the
crucial aspartic acid residue at
position P1 (P4P3P2P1) of Xe-
nopus CD-IC was altered
by site-directed mutagenesis.
The peptide sequence used
for polyclonal antibody pro-
duction is underlined.
Figure 4. Cleavage of Xenopus CD-IC in vitro occurs at DSGD99 and at another, unidentified site. (A) Immunoprecipitated [35S]me-
thionine-labeled wild-type or mutated (DSGA99) CD-IC was incubated in apoptotic Xenopus egg cytosol for the times shown, with or
without Ac-DEVD-CHO or the caspase 3 and 7 inhibitor, Casputin™. Two cleavage products, C1 and C2, are indicated. Note that ap-
pearance of C1 is prevented by Casputin™ and does not occur using CD-IC (DSGA99). (B–D) Immunoprecipitated [35S]methionine-
labeled wild-type or mutated (DSGA99) CD-IC was incubated for 2 h at 30 C with recombinant caspases 2 (B), 3 (C), and 7 (D).
Caspase 2 activity was confirmed by assessing cleavage of in vitro–translated caspase 2, whilst caspases 3 and 7 were tested using in
vitro–translated PARP. (E) Native Xenopus egg cytoplasmic dynein–dynactin was incubated with recombinant caspase 2 (50 nM) or
caspase 3 (20 nM),   Ac-DEVD-CHO for 3 h at 37 C. Proteins were analyzed after SDS-PAGE by immunoblotting (CD-IC was de-
tected using polyclonal antiserum).The Journal of Cell Biology, Volume 153, 2001 1420
Biochemical Analysis of the Cytoplasmic Dynein 
and Dynactin Complexes during Apoptosis
Cytoplasmic dynein and dynactin sediment as separate
complexes of  20S. To test if caspase cleavage of CD-IC
and p150Glued affected the stability of the complexes, we
compared their sedimentation properties when isolated
from control and apoptotic egg cytosol. Motors bind stati-
cally to microtubules in the absence of ATP, so cytoplas-
mic dynein can be enriched from cytosol relatively simply.
Dynactin copurifies with cytoplasmic dynein, since the
p150Glued subunit also possesses a microtubule binding do-
main (between amino acids 39–150; Waterman-Storer et
al., 1995). Silver staining and immunoblotting of sucrose
gradients of cytoplasmic dynein–dynactin-enriched frac-
tions from control egg cytosol revealed that CD-HC, CD-
IC, and CD-LIC cosedimented at 20S (in fractions 5 and 6;
Fig. 5 A). In fractions enriched from apoptotic cytosol,
CD-HC and CD-LIC were still found at 20S, even though
full-length CD-IC could not be detected using 70.1 (Fig. 5
A). Hence, cleavage of CD-IC does not appear to destabi-
lize CD-HC and CD-LIC interactions.
We next asked whether the large COOH-terminal CD-IC
fragment also remained in the complex using an immuno-
precipitation approach (Fig. 5, B and C). In many apoptotic
egg extracts, cleavage of CD-IC is only  60–70% efficient
(Fig. 5 B, lanes 1 and 2). When we immunoprecipitated us-
ing anti–CD-LIC antibodies, we found that the CD-IC
cleavage product, intact CD-IC (Fig. 5 B, lane 4), and CD-
HC (not shown) coprecipitated efficiently. We wanted to
know whether dynein complexes existed which only con-
tained the cleaved CD-IC, and to address this we first de-
pleted dynein containing intact CD-IC by three rounds of
immunoprecipitation with an NH2-terminal monoclonal an-
tibody (1618), which does not recognize cleaved CD-IC
(Fig. 5 C). Interestingly, cleaved CD-IC did not coprecipi-
tate with intact CD-IC (Fig. 5 C, lanes 3–6), but remained in
the unbound fraction (Fig. 5 C, lanes 7 and 8). Moreover,
when we used anti–CD-LIC beads to immunoprecipitate
the remaining dynein from full-length CD-IC–depleted
apoptotic cytosol, the immune complexes contained the
cleaved form of CD-IC along with CD-HC (Fig. 5 C, lane
10). These experiments suggest that, in Xenopus egg cyto-
sol, cleavage of CD-IC chains does not cause the dynein
components to disassociate. Strikingly, the dynein com-
plexes contain either all intact or all cleaved CD-ICs.
Sucrose density gradient analysis also provided infor-
mation on the dynactin complex. Using the monoclonal
anti-p150Glued antibody, we found that in control cytosol
p150Glued sedimented at 20S as expected (Fig. 5 A). In ap-
optotic cytosol, we detected some full-length p150Glued at
20S (Fig. 5 A), since cleavage of p150Glued is incomplete
(Fig. 1 C). Although some cleaved p150Glued also migrated
to this position (Fig. 5 A), the majority was detected at the
top of the gradient, suggesting that it had dissociated from
the dynactin complex (Fig. 5 A). The method for isolating
cleaved (and intact) p150Glued relies on microtubule affin-
ity, suggesting that the truncated product contains a func-
tional microtubule binding domain (although some may
be complexed with the small amount of intact, free
p150Glued). Moreover, the monoclonal p150Glued antibody
used was raised against the NH2-terminal microtubule
binding domain of p150Glued, so it seems likely that the cas-
pase cleavage site(s) within Xenopus p150Glued is located
towards its COOH terminus.
Figure 5. The fate of cytoplasmic dynein and dynactin complexes in apoptotic extracts. (A) Microtubule motors were isolated from
control or apoptotic Xenopus egg cytosol by microtubule affinity, then separated on sucrose density gradients and analyzed by silver
staining and immunoblotting (CD-IC was detected using 70.1). CD-HC was not seen in fraction 1 of the apoptotic gradient: the silver
staining in that lane is artefactual. (B) The cytoplasmic dynein complex was immunoprecipitated from control (C) and apoptotic (A)
egg cytosols using anti–CD-LIC antibody, and immunoblotted with polyclonal anti–CD-IC peptide antibody to detect cleaved (  )
and intact ( ) CD-IC. (C) Control (C; lane 1) and apoptotic (A; lane 2) egg cytosols were depleted of any cytoplasmic dynein complex
containing uncleaved CD-IC by three rounds of depletion using the monoclonal antibody, 1618, against the NH2-terminus of CD-IC
(beads from only rounds 1 and 3 are shown; lanes 3–6). The depleted cytosols (lanes 7 and 8) were then subjected to a further immuno-
precipitation with anti–CD-LIC beads (lanes 9 and 10). All fractions were examined by silver stain for DHC (top) and immunoblotted
with anti–CD-IC peptide antibody to detect cleaved (  ) and uncleaved ( ) CD-IC (bottom).Lane et al. Apoptotic Loss of Cytoplasmic Dynein Function 1421
Cleavage of CD-IC and p150Glued Stops Cytoplasmic 
Dynein–driven Membrane Motility In Vitro
According to current models, caspase-mediated cleavage
of CD-IC and p150Glued should uncouple cytoplasmic dy-
nein from its cargo and therefore prevent movement along
microtubules. We tested this hypothesis using two ap-
proaches. First, we determined whether cytoplasmic dy-
nein and dynactin remained membrane-associated in egg
extracts during apoptosis, and then we looked at the con-
sequences of apoptotic CD-IC and p150Glued cleavage on
membrane motility using an in vitro assay. Floated Xeno-
pus egg membranes are rich in both cytoplasmic dynein
and dynactin (Fig. 6; Lane and Allan, 1999). Although sil-
ver staining revealed very little difference in the overall
protein pattern in apoptotic versus control cytosol or
membranes (Fig. 6 A), the apoptotic membranes had lost
most of their associated CD-LIC and CD-IC (Fig. 6 B).
Since the cytoplasmic dynein complex remains intact dur-
ing apoptosis (Fig. 5), it is likely that the entire complex is
removed from membranes during this process.
We then looked at the dynactin complex. The amount of
full-length and cleaved p150Glued on apoptotic membranes
was greatly reduced, and p50 dynamitin also appeared to
be depleted (Fig. 6 B). Membrane-associated Arp-1 was
partially degraded to an  32-kD product in apoptotic egg
extracts, which remained associated with membranes (no
degradation was observed in apoptotic cytosol; Fig. 6 B).
We do not know if the Arp-1 degradation product is due
solely to the action of caspases, because we always ob-
served a similar band in immunoblots of control mem-
branes (Fig. 6 B). Taken together, these results suggest
that at least part of the dynactin complex stays on apop-
totic membranes. We also compared KHC and kinesin II
on control and apoptotic membranes (Fig. 6 B). Interest-
ingly, while the amounts of kinesin II (p85 subunit) did not
change, we found that KHC, although uncleaved (Figs. 1
A and 6 B), was lost from apoptotic egg membranes, an
observation which merits further investigation.
ER membranes present in crude frog egg extracts move
exclusively using cytoplasmic dynein in egg cytosol and are
easily identified by VE-DIC microscopy (Allan, 1995;
Niclas et al., 1996; Lane and Allan, 1999). Therefore, we
used in vitro motility assays to assess cytoplasmic dynein–
based membrane motility in control and apoptotic egg ex-
tracts. Extensive ER networks formed from membranes
and cytosol derived from control extracts treated with cy-
tochrome c and caspase inhibitors (Fig. 7 A, left). The mo-
tility of these networks was identical to that seen in un-
treated extracts. However, upon combining membranes
and cytosol from apoptotic extracts, we saw no network
formation (Fig. 7 A, right). Instead, membrane clumps
rarely associated with microtubules (Fig. 7 A), and tubule
extension events were never observed. We have not as-
sessed whether ER membrane fusion is also inhibited, but
this is a possibility given that homotypic endosome fusion
is a target for apoptotic regulation (via caspase 3 cleavage
of Rabaptin 5; Cosulich et al., 1997; Swanton et al., 1999a).
These data suggest that apoptotic membranes are un-
able to form networks in apoptotic cytosol because they
have lost the capacity to associate with and move along
microtubules in a cytoplasmic dynein–dependent fashion.
However, when apoptotic membranes were incubated in
control cytosol, they regained the ability to move along
microtubules and undergo homotypic membrane fusion
(Fig. 7 B, left), generating networks which were  75% as
extensive as seen in nonapoptotic conditions. When we
carried out the reciprocal experiment (control membranes
in apoptotic cytosol), we found that the extent of network
formation was similar (Fig. 7 B, right). All experiments
were performed in the presence of caspase inhibitor to
prevent further caspase action.
When the membranes from these incubations were re-
isolated and immunoblotted for cytoplasmic dynein and
dynactin, we found that apoptotic membranes effectively
recruited full-length CD-IC and CD-LIC, as well as
p150Glued, to  50% of control levels in just 1 h (Fig. 8), al-
though under identical conditions KHC was not recruited
(data not shown). Control membranes lost a proportion of
Figure 6. The cytoplasmic
dynein complex is released
from membranes during apop-
tosis in Xenopus egg extracts.
Cytosol (Cyt) and mem-
branes (Mem) were prepared
from control or apoptotic ex-
tracts (C and A, respectively).
Equal amounts of protein
were loaded on SDS-PAGE
gels, silver stained for total
protein (A) and immuno-
blotted using the antibodies
shown (B).The Journal of Cell Biology, Volume 153, 2001 1422
their associated cytoplasmic dynein and dynactin when in-
cubated in apoptotic cytosol for 1 h (Fig. 8). This probably
reflects the dynamic nature of cytoplasmic dynein’s affin-
ity for membranes and is not due to caspase activity, be-
cause Ac-DEVD-CHO was included in these assays.
We next asked whether membrane movement in ap-
optotic extracts could be restored by the addition of puri-
fied cytoplasmic dynein–dynactin. We incubated apoptotic
membranes and cytosol (plus Ac-DEVD-CHO) in the
presence of pig brain cytoplasmic dynein–dynactin (Fig.
9). This fraction restored the network-forming ability of
apoptotic membranes to  25% of control activity (Fig. 9
A). The addition of pig brain cytoplasmic dynein brought
the amount of intact CD-IC present in the cytosol/mem-
brane mixture to approximately control levels (Fig. 9
B). These results suggest that cytoplasmic dynein–driven
ER motility is halted during apoptosis primarily through
caspase-mediated cleavage of cytoplasmic dynein and dy-
nactin components.
Discussion
We have investigated the fate of cytoplasmic dynein dur-
ing apoptosis, both in vivo and in vitro, as part of an ongo-
ing study into alterations in membrane traffic and cellular
organization. We have used Xenopus egg extracts as a
well-characterized model system, as they support regu-
lated cytoplasmic dynein–driven ER movement (Allan,
1995; Niclas et al., 1996; Lane and Allan, 1999) and can be
driven into apoptosis by the addition of cytochrome c
(Kluck et al., 1997).
We have identified CD-IC as a target for caspase-depen-
dent cleavage both in vivo and in cell-free extracts, and have
demonstrated by site-directed mutagenesis and the use of
specific antibodies that cleavage results in the loss of the
NH2-terminal p150Glued-binding domain. In contrast, CD-
HC and CD-LIC are unaffected and remain as a complex
containing the COOH-terminal cleavage product of CD-IC.
Interestingly, we found that dynein complexes either con-
tained only full length or only cleaved CD-IC, suggesting
that once a dynein molecule is targeted by the caspase
(probably caspase 3), all the CD-IC chains are cleaved.
The p150Glued component of dynactin is also cleaved, and
most of the cleaved form no longer migrates as part of the
20S dynactin complex on sucrose density gradients. Since
cleaved p150Glued seems to maintain its ability to bind to mi-
crotubules and is still recognized by an antibody to its NH2-
terminal domain, it is likely that the cleavage occurs in its
COOH-terminal domain, through which it interacts with
the rest of the dynactin complex (Waterman-Storer et al.,
1995). This behavior is remarkably similar to that of the
COOH-terminally truncated product of the dominant
Glued1 mutant gene in Drosophila (McGrail et al., 1995). It
will clearly be of interest to map the p150Glued cleavage site
in future studies. Since some dynamitin and Arp1 stay
bound to the membrane, this may mean that the dynactin
complex minus p150Glued is left behind. However, lack of an-
tibodies recognizing other Xenopus dynactin components
has prevented a thorough investigation of this question.
The cleavage of these two key components, CD-IC and
p150Glued, would be predicted to destroy cytoplasmic dy-
nein’s ability to bind to and therefore move cargo (Fig. 10),
Figure 7. Motile properties of apoptotic and nonapoptotic
membranes. (A) Membranes were prepared by flotation from
control and apoptotic Xenopus egg extracts, then incubated in
their respective cytosols for 45 min. They were then assayed for
motility using a three way junction index (see Materials and
Methods). (B) Control or apoptotic cytosols and membranes
were mixed as indicated, and assayed for motility as above. Val-
ues are means   SEM for three independent experiments. In
each case, Ac-DEVD-CHO was added to a final concentration of
2  M before motility assays. Representative VE-DIC fields (27
 m across) are also shown for each assay.Lane et al. Apoptotic Loss of Cytoplasmic Dynein Function 1423
and we have shown this to be the case for cytoplasmic dy-
nein–driven ER motility in apoptotic Xenopus egg extracts.
Interestingly, apoptotic membranes recruit intact cytoplas-
mic dynein and dynactin from control cytoplasm, and re-
gain the ability to form ER networks. Moreover, the addi-
tion of a pig brain cytoplasmic dynein fraction (which also
contains dynactin) to a mixture of apoptotic cytosol and
membranes was sufficient to reconstitute network forma-
tion partially. Although the amount of pig brain dynein
added matched that present in control cytosol, motility was
not fully restored. There are many possible explanations for
this: first, we do not know how much of this dynein is re-
cruited to the membrane; second, the purified dynein frac-
tion may be partially inactive, or take time to become acti-
vated when added to cytosol; third, the concentration of
dynactin may be too low; and fourth, there may be other
factors that are absent in apoptotic cytosol that are required
to restore full motility. Together, however, our data suggest
that cytoplasmic dynein and dynactin are primary targets
for the caspase-dependent abrogation of ER tubule move-
ment described here. Any cleavage of integral membrane
proteins by caspases cannot be inhibiting cytoplasmic dy-
nein binding in our assay, as such changes would not be re-
versible.
Our results clearly demonstrate that the interaction of
cytoplasmic dynein and dynactin with the membrane is dy-
namic, and suggests that there is rapid turnover, at least in
the presence of apoptotic cytosol. This is in keeping with
other studies in Xenopus, which have revealed that both
cytoplasmic dynein and dynactin are rapidly released from
membranes on entry into metaphase (Niclas et al., 1996;
Addinall et al., 2001), or when anti–CD-IC antibodies are
added to interphase extracts (Steffen et al., 1997). Similar
loss of cytoplasmic dynein from membranes occurred after
the addition of anti-p150Glued antibodies to squid axoplasm
(Waterman-Storer et al., 1997) and under certain condi-
tions in cultured mammalian cells (Lin et al., 1994). In ad-
dition, overexpression of the dynamitin subunit of dynac-
tin causes loss of cytoplasmic dynein from kinetochores
(Echeverri et al., 1996) and the Golgi apparatus (Roghi
and Allan, 1999), again demonstrating that cytoplasmic
dynein–cargo interaction is dynamic.
What is the significance of these cleavage events to the
apoptosing cell? As yet, we can only speculate, but it is
clear that CD-IC in particular is an early target for cleav-
age, which proceeds in parallel with PARP cleavage.
Given that inhibition of cytoplasmic dynein function dis-
rupts ER-to-Golgi apparatus traffic (Presley et al., 1997)
and leads to a scattering of the Golgi apparatus through-
Figure 8. Apoptotic membranes can recruit intact cytoplasmic
dynein and dynactin. Membranes from control (C) or apoptotic
(A) egg extracts were incubated in control or apoptotic cytosol
for 1 h. Membranes were then recovered and equal protein sam-
ples were run on SDS-PAGE and immunoblotted (antiribo-
phorin was used as a loading control).
Figure 9. Addition of purified pig brain cytoplasmic dynein–
dynactin restores ER network formation. (A) Membranes were
prepared by flotation from apoptotic egg extracts, and incubated
for 45 min in apoptotic cytosol in the presence or absence of pig
brain cytoplasmic dynein–dynactin (CD). To avoid apoptotic
cleavage of the added motor components, 2  M Ac-DEVD-CHO
was included in the motility assays. Values are means   SEM for
three independent experiments. (B) Total samples from a pig
brain dynein–dynactin add-back experiment were immunoblotted
using the antibodies shown (C, control cytosol and membranes; A,
apoptotic cytosol and membranes). Anti–CD-IC antibodies: i,
70.1; ii, anti-Xenopus CD-IC peptide antibody; iii, Xenopus-spe-
cific NH2-terminal antibody. The position of the added pig brain
motor components ( ) and the Xenopus p150Glued and CD-IC
cleavage products (3) are shown. In contrast to Fig. 8, total sam-
ples, not re-isolated membranes, were analyzed.The Journal of Cell Biology, Volume 153, 2001 1424
out the cell (Burkhardt et al., 1997; Quintyne et al., 1999;
Roghi and Allan, 1999), it is intriguing to note that Golgi
apparatus fragmentation is seen in apoptotic cells (Man-
cini et al., 2000). It will be of great interest to know if the
loss of cytoplasmic dynein from the Golgi apparatus con-
tributes to this phenotype, and whether ER-to-Golgi ap-
paratus traffic is also inhibited due to a lack of motor.
In this study, we have investigated the effects of apopto-
sis on membrane movement, but since cytoplasmic dynein
plays many different roles in the cell, it is plausible that in-
terrupting other cytoplasmic dynein–driven motile events
may also be important for apoptosis. Another issue is that
the cleavage site that we have identified in Xenopus CD-
IC, DSGD99G, is conserved in all rat CD-IC2 splice forms
but not in rat CD-IC1. The cytoplasmic dynein intermedi-
ate chain family is encoded by two genes, of which CD-IC1
is expressed only in brain and testis, while CD-IC2 is
found in all tissues (for review see Susalka et al., 2000).
Therefore, all cells are likely to contain a cleavable CD-
IC, while neurons and testis may also possess a form that
lacks this caspase cleavage site. This may provide a means
of differentially regulating the function of distinct cyto-
plasmic dynein complexes during apoptosis.
Cytoplasmic dynein has been proposed to play a direct
role in an early, caspase-independent signaling event dur-
ing apoptosis. The cytoplasmic dynein light chain, LC8,
and the proapoptotic protein Bim (O’Connor et al., 1998)
are stably associated with each other in healthy cells, and
translocate to Bcl-2 shortly after triggering apoptosis (Pak-
thalakath et al., 1999). Hence, caspase-dependent inacti-
vation of the cytoplasmic dynein–dynactin complex might
provide a positive feed-back loop during activation of the
apoptotic cascade. However, LC8 is also a component of
flagellar dynein, myosin V, I B  and nitric oxide synthase
(for review see King, 2000). In addition, the expression of
LC8 is increased by cyclooxygenase 2 treatment of PC12
cells, where it is thought to protect from growth factor
withdrawal-induced apoptosis by the inhibition of nitric
oxide synthesis (Chang et al., 2000). Therefore, because of
the apparent promiscuous behavior of LC8, and in the ab-
sence of definitive evidence that Bim is part of the native
cytoplasmic dynein complex, it remains unclear whether
the cleavage of CD-IC that we observe here will have any
direct effects on the Bim-LC8 interaction.
Little else is known about the roles that microtubule
motors play in apoptosis. An inhibition of the plus end–
directed microtubule motor, kinesin, has been implicated
in the clustering of mitochondria that occurs on triggering
cell death via tumor necrosis factor (De Vos et al., 1998,
2000), but as a shift in mitochondrial position did not occur
after other apoptotic stimuli, it is not clear if this is a gen-
eral phenomenon. Whether inactivation of kinesin is also
responsible for Bax-induced mitochondrial clustering (De-
sagher and Martinou, 2000) remains to be tested. Interest-
ingly, our results show that kinesin, like dynein, was re-
leased from apoptotic membranes (Fig. 6), but it was not
rerecruited from control cytosol (data not shown). Al-
though KHC is not cleaved in apoptotic egg extracts, we
do not yet know if kinesin light chains, which are thought
to target kinesin to its cargoes (Hollenbeck, 2001), are af-
fected. In addition, since caspase-induced cleavage of ki-
nectin has been seen in apoptotic cultured cells (Machleidt
et al., 1998), this raises the possibility that kinectin is also
cleaved on apoptotic membranes in our assay system, and
that this prevents rerecruitment.
The identification of cytoplasmic dynein and dynactin as
targets for degradation adds to the list of key cytoskeletal
(Brancolini et al., 1995; Caulín et al., 1997; Mills et al.,
1999) and trafficking molecules (Cosulich et al., 1997;
Swanton et al., 1999a; Mancini et al., 2000) that are
cleaved during the crucial process of apoptosis. A key is-
sue will be to understand how these changes together ex-
pedite the recognition and clearance of apoptotic cells.
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Figure 10. Diagram showing the predicted effects of CD-IC and
p150Glued cleavage on cytoplasmic dynein–driven organelle motil-
ity. Cleavage leads to the removal of the p150Glued-binding domain
of CD-IC, rendering cytoplasmic dynein incapable of binding to,
and hence moving, its cargoes. Cleavage of p150Glued, which oc-
curs more slowly, removes the microtubule-binding capacity of
the dynactin complex, which may ensure that cargoes cannot asso-
ciate with microtubules. Our results suggest that p50 dynamitin is
also partially released from cargo (not shown in model).Lane et al. Apoptotic Loss of Cytoplasmic Dynein Function 1425
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